Literature DB >> 21533404

Cyclooxygenase-2 gene expression in human breast cancer.

M Parrett1, R Harris, F Joarder, M Ross, K Clausen, F Robertson.   

Abstract

Expression of the inducible isoform of the cyclooxygenase gene (PGHS-2, COX-2) which codes for the enzyme that catalyzes formation of prostaglandins, was detected in 13/13 human breast tumors of high grade but not in samples of normal breast tissue. There was a statistically significant linear association between COX-2 gene expression and high (>50%) tumor cell density (p<0.01), with COX-2 protein localized to tumor cells. These results indicate that COX-2 gene expression may be useful as a molecular biomarker for human breast tumors and may also predict sensitivity to treatment with nonsteroidal anti-inflammatory drugs.

Entities:  

Year:  1997        PMID: 21533404     DOI: 10.3892/ijo.10.3.503

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  40 in total

1.  Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4.

Authors:  Fredika M Robertson; Ann-Marie Simeone; Anthony Lucci; John S McMurray; Sukhen Ghosh; Massimo Cristofanilli
Journal:  Cancer       Date:  2010-06-01       Impact factor: 6.860

2.  Impact of cyclooxygenase-2 over-expression on the prognosis of breast cancer patients.

Authors:  Sertaç Ata Güler; Mustafa Ümit Uğurlu; Handan Kaya; Semiha Şen; Yasemin Nazlı; Bahadır M Güllüoğlu
Journal:  Ulus Cerrahi Derg       Date:  2015-06-01

3.  Cyclo-oxygenase 2 and breast cancer prevention. Non-steroidal anti-inflammatory agents are worth testing in breast cancer.

Authors:  H Vainio; G Morgan
Journal:  BMJ       Date:  1998-09-26

4.  Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.

Authors:  Tae Jung Jang; Ho Guen Jung; Ki Hoon Jung; Min Ku O
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

5.  Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner.

Authors:  Anushka Dikshit; Manoel Adrião Gomes Filho; Erfan Eilati; Stacey McGee; Carrie Small; Chunqi Gao; Thomas Klug; Dale Buchanan Hales
Journal:  Br J Nutr       Date:  2015-04-08       Impact factor: 3.718

6.  Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

Authors:  C Costa; R Soares; J S Reis-Filho; D Leitão; I Amendoeira; F C Schmitt
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

7.  Clinical value of cyclooxygenase-2 expression in human breast carcinoma.

Authors:  Jin-Hee Ahn; Sung-Bae Kim; Sei-Hyun Ahn; Gyung-Yub Gong; Myung-Ju Ahn; Yoon-Koo Kang; Jung-Shin Lee; Woo Kun Kim
Journal:  Cancer Res Treat       Date:  2004-06-30       Impact factor: 4.679

8.  Analysis of metabolites and metabolic pathways in breast cancer in a Korean prospective cohort: the Korean Cancer Prevention Study-II.

Authors:  Hye Jin Yoo; Minjoo Kim; Minkyung Kim; Minsik Kang; Keum Ji Jung; Se-Mi Hwang; Sun Ha Jee; Jong Ho Lee
Journal:  Metabolomics       Date:  2018-06-08       Impact factor: 4.290

9.  In vitro effects on MCF-7 breast cancer cells of signal transduction inhibitor/tamoxifen/eicosapentaenoic acid combinations and their simultaneous delivery across skin.

Authors:  Zoë Davison; Carol Dutkowski; Julia M W Gee; Robert I Nicholson; Charles M Heard
Journal:  Pharm Res       Date:  2008-07-12       Impact factor: 4.200

Review 10.  Nitrative and oxidative stress in toxicology and disease.

Authors:  Ruth A Roberts; Debra L Laskin; Charles V Smith; Fredika M Robertson; Erin M G Allen; Jonathan A Doorn; William Slikker
Journal:  Toxicol Sci       Date:  2009-08-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.